These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36799248)

  • 1. Pre-analytical considerations in the development of a prototype SARS-CoV-2 antigen ARCHITECT automated immunoassay.
    Hemken PM; Israeli E; Taylor R; Jacobson C; Datwyler M; Geissler R; Hadji A; Jeanblanc N; Pandya K; Marcinkus M; Piktel R; Bogdan MF; Rodgers M; Anderson M; Ziemann R; Tieman BC; Hawksworth D; Moore J; Otis KS; Marohnic CC; Corby J; Tu B; Lin Z; Kar A; Hartnett J; Strobel C; Gregory S; Rae T; Muerhoff AS; Brophy S; Hackett JR; Daghfal D; Faron ML; Cruz A; Mohr P; Sokoll L; Davis GJ
    Clin Chem Lab Med; 2023 Jul; 61(8):1511-1517. PubMed ID: 36799248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-Institutional Evaluation of the Abbott ARCHITECT SARS-CoV-2 IgG Immunoassay.
    Wiencek JR; Bachmann LM; Dinwiddie K; Miller GW; Bazydlo LAL
    Lab Med; 2021 Sep; 52(5):e137-e146. PubMed ID: 33929022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-Pandemic and Pandemic Patient Populations.
    Yang J; Pederson EC; Hamilton C; Neibauer T; Robyak K; McGhee P; Speicher T; Zhu Y
    J Appl Lab Med; 2021 Mar; 6(2):441-450. PubMed ID: 33152084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of SARS-CoV-2 antigen electrochemiluminescence immunoassay to RT-PCR assay for laboratory diagnosis of COVID-19 in Peshawar.
    Iqbal B; Khan M; Shah N; Dawood MM; Jehanzeb V; Shafi M
    Diagnosis (Berl); 2022 Aug; 9(3):364-368. PubMed ID: 34455727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test.
    Meschi S; Colavita F; Bordi L; Matusali G; Lapa D; Amendola A; Vairo F; Ippolito G; Capobianchi MR; Castilletti C;
    J Clin Virol; 2020 Aug; 129():104539. PubMed ID: 32679298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a high-sensitivity SARS-CoV-2 antigen test on the fully automated light-initiated chemiluminescent immunoassay platform.
    Yu M; Chen D; Tang X; Zhang Y; Liang P; Xiong Y; Li R; Song R; Chen X; Zhao X; Wang X; Jin R
    Clin Chem Lab Med; 2023 May; 61(6):1123-1130. PubMed ID: 36656975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tergitol-15-S-9 inactivates SARS-CoV-2 and boosts immunoassay signals.
    Berg MG; Israeli E; Quaco E; Cloherty GA; Hemken PM
    Biotechniques; 2021 Jul; 71(1):370-375. PubMed ID: 34139879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of storage temperatures simulating transport conditions of nasopharyngeal swabs on the results of a chemiluminescence immunoassay (CLIA) to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen.
    Kanta P; Ghosh A; Goyal K; Kaur R; Baluni M; Sircar S; Kumar V; Kumar K; Vijay N; Singh MP
    Indian J Med Microbiol; 2023; 44():100379. PubMed ID: 37356827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance evaluation of Elecsys SARS-CoV-2 Antigen immunoassay for diagnostic of COVID-19.
    Montalvo Villalba MC; Sosa Glaria E; Rodriguez Lay LLA; Valdés Ramirez O; Vallina García D; Arencibia Garcia A; Martinez Alfonso J; Menes Llerena DM; Torres Pérez L; Resik Aguirre SR; Guzman Tirado MG
    J Med Virol; 2022 Mar; 94(3):1001-1008. PubMed ID: 34676585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassay.
    Riester E; Findeisen P; Hegel JK; Kabesch M; Ambrosch A; Rank CM; Pessl F; Laengin T; Niederhauser C
    J Virol Methods; 2021 Nov; 297():114271. PubMed ID: 34461153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay.
    Pighi L; Henry BM; De Nitto S; Gianfilippi G; Salvagno GL; Plebani M; Lippi G
    Clin Chem Lab Med; 2023 Jul; 61(8):1506-1510. PubMed ID: 36883744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method for detection of SARS-CoV-2 RNA in healthy human stool: a validation study.
    Coryell MP; Iakiviak M; Pereira N; Murugkar PP; Rippe J; Williams DB; Heald-Sargent T; Sanchez-Pinto LN; Chavez J; Hastie JL; Sava RL; Lien CZ; Wang TT; Muller WJ; Fischbach MA; Carlson PE
    Lancet Microbe; 2021 Jun; 2(6):e259-e266. PubMed ID: 33821247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen Test.
    Matsuzaki N; Orihara Y; Kodana M; Kitagawa Y; Matsuoka M; Kawamura R; Takeuchi S; Imai K; Tarumoto N; Maesaki S; Maeda T
    J Med Virol; 2021 Dec; 93(12):6778-6781. PubMed ID: 34170555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance characteristics of the Abbott Alinity m SARS-CoV-2 assay.
    Perchetti GA; Pepper G; Shrestha L; LaTurner K; Yae Kim D; Huang ML; Jerome KR; Greninger AL
    J Clin Virol; 2021 Jul; 140():104869. PubMed ID: 34023572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical performance and sample freeze-thaw stability of the cobas®6800 SARS-CoV-2 assay for the detection of SARS-CoV-2 in oro-/nasopharyngeal swabs and lower respiratory specimens.
    Stohr JJJM; Wennekes M; van der Ent M; Diederen BMW; Kluytmans-van den Bergh MFQ; Bergmans AMC; Kluytmans JAJW; Pas SD
    J Clin Virol; 2020 Dec; 133():104686. PubMed ID: 33221622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copan eNAT Transport System To Address Challenges in COVID-19 Diagnostics in Regions with Limited Testing Access.
    Richard-Greenblatt M; Comar CE; Flevaud L; Berti M; Harris RM; Weiss SR; Glaser L
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33579730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Reagent and Virus Benchmarking Panel for a Uniform Analytical Performance Assessment of N Antigen-Based Diagnostic Tests for COVID-19.
    Golden A; Cantera JL; Lillis L; Phan TT; Slater H; Webb EJ; Peck RB; Boyle DS; Domingo GJ
    Microbiol Spectr; 2023 Jun; 11(3):e0373122. PubMed ID: 37166329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of the fully automated Roche Elecsys SARS-CoV-2 antigen electrochemiluminescence immunoassay: a pooled analysis.
    Lippi G; Henry BM; Adeli K
    Clin Chem Lab Med; 2022 Apr; 60(5):655-661. PubMed ID: 35114742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Direct-Specimen SARS-CoV-2 Assay Performance Using Residual Patient Samples.
    Schroeder LF; Bachman MA; Idoni A; Gegenheimer-Holmes J; Kronick SL; Valdez R; Lephart PR
    J Appl Lab Med; 2022 May; 7(3):661-673. PubMed ID: 34755849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of the Elecsys SARS-CoV-2 antigen assay in the clinical routine of a tertiary care hospital: Preliminary results from a single-center evaluation.
    Mueller T; Kompatscher J; La Guardia M
    J Clin Lab Anal; 2021 Aug; 35(8):e23906. PubMed ID: 34251047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.